DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Kaul S.
Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials.
Diabetes Care 2017;
40 (07) 821-831
We do not assume any responsibility for the contents of the web pages of other providers.